Department of pharmacy, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang 441000, China.
School of Basic Medical Sciences, Zhengzhou University, Zhengzhou 450001, China.
Biomed Pharmacother. 2024 Sep;178:117196. doi: 10.1016/j.biopha.2024.117196. Epub 2024 Jul 24.
Necroptosis is a crucial modality of programmed cell death characterized by distinct morphological and biochemical hallmarks, including cell membrane rupture, organelle swelling, cytoplasmic and nuclear disintegration, cellular contents leakage, and release of damage-associated molecular patterns (DAMPs), accompanied by the inflammatory responses. Studies have shown that necroptosis is involved in the etiology and evolution of a variety of pathologies including organ damage, inflammation disorders, and cancer. Despite its significance, the field of necroptosis research grapples with the challenge of non-standardized detection methodologies. In this review, we introduce the fundamental concepts and molecular mechanisms of necroptosis and critically appraise the principles, merits, and inherent limitations of current detection technologies. This endeavor seeks to establish a methodological framework for necroptosis detection, thereby propelling deeper insights into the research of cell necroptosis.
细胞程序性坏死是一种重要的细胞死亡方式,具有独特的形态学和生化特征,包括细胞膜破裂、细胞器肿胀、细胞质和细胞核解体、细胞内容物泄漏以及损伤相关分子模式(DAMPs)的释放,同时伴有炎症反应。研究表明,细胞程序性坏死参与了多种病理学的发病机制和演变,包括器官损伤、炎症紊乱和癌症。尽管具有重要意义,但细胞程序性坏死研究领域仍面临检测方法不标准化的挑战。在这篇综述中,我们介绍了细胞程序性坏死的基本概念和分子机制,并批判性地评估了当前检测技术的原理、优点和固有局限性。这项工作旨在为细胞程序性坏死的检测建立方法学框架,从而推动对细胞程序性坏死研究的深入了解。